Approval · Notice of Compliance 10132 · 2009
CRIXIVAN: Notice of Compliance 10132
Issued April 6, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10132
- Date
- April 6, 2009
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revisions to the product monograph
- Therapeutic class
- Hiv protease inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CRIXIVAN | Not yet assigned | — |
Medicinal ingredients
- INDINAVIR SULFATE 200 MG per CAP
- INDINAVIR SULFATE 400 MG per CAP